L. Musset

TL;DR: Recommendations for the assessment and interpretation of ANA and associated antibodies were formulated and the roles of IIFA as a reference method, and the importance of defining nuclear and cytoplasmic staining were emphasised, while the need to incorporate alternative automated methods was acknowledged.

TL;DR: An overview of the (clinical) performance characteristics of monospecific assays as well as of multispecificAssays for detection of myositis-specific autoantibodies is given and it is discussed that efforts are needed to harmonize and standardize detection of MSA.

TL;DR: In this article, the authors report 22 patients with chronic sensory polyneuropathy with ≥ 1 clinical sign atypical for chronic idiopathic axonal polyneurpathy (CIAP) but no electrodiagnostic criteria for CIDP.

TL;DR: To elucidate the diagnostic value of sarcoplasmic expression of myxovirus resistance protein A for dermatomyositis (DM) specifically analysing different DM subforms, and to test the superiority of MxA to other markers.

TL;DR: The results reveal not only apparent differences between countries, but also within countries, and awareness of these differences may also direct recommendations that may further contribute to achieving the EASI goal of harmonisation of autoimmune diagnostics for SARD.